Caroline Litchfield
Director of Finance/CFO bij IMMUNE DESIGN CORP
Vermogen: 7 M $ op 31-03-2024
Profiel
Mevrouw Caroline A. Litchfield is Chief Financial Officer & Director bij Immune Design Corp. en Chief Financial Officer & Executive Vice President bij Merck & Co., Inc. Zij zit in de Raad van Bestuur van Immune Design Corp. Mevrouw Litchfield was voorheen werkzaam als financieel directeur bij Merck Sharp & Dohme Ltd. Zij behaalde haar doctoraal aan de Universiteit van Leicester.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MERCK & CO., INC.
0.00% | 14-02-2024 | 50 908 ( 0.00% ) | 7 M $ | 31-03-2024 |
Actieve functies van Caroline Litchfield
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNE DESIGN CORP | Director of Finance/CFO | - |
| MERCK & CO., INC. | Director of Finance/CFO | 01-04-2021 |
Eerdere bekende functies van Caroline Litchfield
| Bedrijven | Functie | Einde |
|---|---|---|
| ORGANON & CO. | Director/Board Member | 31-05-2021 |
| FULFORD (INDIA) LIMITED | Director/Board Member | 30-01-2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | 23-06-2009 |
Opleiding van Caroline Litchfield
| University of Leicester | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
